Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Artificial Saliva Market From 2025 To 2029?

In recent years, the market size for artificial saliva has seen a significant increase, expanding from $1.95 billion in 2024 to an expected $2.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.9%. The growth encountered during this historic period can be associated with the increasing demand for oral sprays, oral gels, and oral liquids. It can also be attributed to broader treatment options available for cancer patients, a growing elder population, an increase in disposable income, and a global rise in dental disorders.

What Is the Projected Market Size of the Artificial Saliva Market?

The market for artificial saliva is predicted to experience robust expansion in the next few years, with projections for it to reach a value of $3.72 billion in 2029, an increase at a compound annual growth rate (CAGR) of 13.7%. This projected growth during the forecast period can be ascribed to the escalating public enlightenment on oral hygiene, the growing occurrence of xerostomia or dry mouth syndrome, heightened demand for artificial saliva, the increasing prevalence of cancer, and a surge in chemotherapy treatment. Upcoming trends for the forecast period encompass an escalation in research and development activities, improvements in product formulae, the integration of cutting-edge technologies, advancements in the treatment of dry mouth, and a shift towards natural and biocompatible ingredients.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16592&type=smp

Who are the Major Competitors in the Artificial Saliva Market Outlook?

Major companies operating in the artificial saliva market are Pfizer Inc., Amgen Inc., Viatris Inc., Bausch Health Companies Inc., Perrigo Company plc, Aurobindo Pharma, Cipla, Hikma Pharmaceuticals plc, RECORDATI, Mankind Pharma Ltd., Quantum Health Inc., Mission Pharmacal Company, Cumberland Pharmaceuticals Inc., DENTAID, Parnell Pharmaceuticals Inc., Forward Science, ICPA Health Products Ltd., Saliwell Ltd., Livealth, CCMed Ltd., Nanochemazone

What Is Fueling Growth in the Artificial Saliva Market?

An increasing occurrence of dry mouth syndrome, also called xerostomia, is forecasted to enhance the growth of the artificial saliva market in the future. This condition, resulting in a continuous sensation of dryness in the mouth, is increasingly common due to factors like an aging population and the pervasive use of medication and over-the-counter drugs, which can trigger xerostomia. To mitigate this problem, artificial saliva is used to moisten oral tissues and reduce the uncomfortable dry feeling usually related to xerostomia. Evidence from a study by Faculdade Meridional, a dentistry school in Brazil, showed a 19.1% xerostomia prevalence rate amongst a sample of 293 older Brazilian adults in 2021. In correspondence, a research study by the University of Gothenburg, a university in Sweden, revealed a xerostomia prevalence rate of 43.6% from a survey of 374 adult patients seeking primary healthcare in 2022. These statistics underline the driving role of increasing cases of dry mouth syndrome on the growth of the artificial saliva market. As another driver, the upward trend of cancer cases is predicted to fuel the growth of the artificial saliva market in the future. With abnormal cells multiplying uncontrollably, cancer can be life-threatening if not treated. The number of cancer cases is escalating due to several factors including an aging population, lifestyle adaptations, higher risk exposure and enhanced detection methods. Artificial saliva proves beneficial to cancer patients experiencing dry mouth as a side effect of treatments like chemotherapy or radiation, leading to a reduction in natural saliva production. This improves their comfort level and oral health. A report published by the Australian Institute of Health and Welfare in August 2024 projects that by 2034, Australia will see approximately 209,000 new cancer diagnoses, a marked rise from the estimated 169,000 cases expected in 2024. This mirrors the effect of a growing population and increasing cancer cases. Added to this, cancer is expected to be the cause of nearly 3 out of every 10 deaths in the country in 2024. Consequently, the intensifying burden of cancer is fueling the market for artificial saliva.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16592&type=smp

Which Artificial Saliva Market Segments Are Growing the Fastest?

The artificial saliva market covered in this report is segmented –

1) By Product: Oral Spray, Oral Solution, Oral Liquid, Dissolving Tablets, Gel, Powder

2) By Distributional Channel: Supermarkets, Hypermarkets, Other Distribution Channels

3) By End-User: Adult, Pediatric

Subsegments:

1) By Oral Spray: Non-Alcoholic Oral Spray, Alcohol-Based Oral Spray

2) By Oral Solution: Ready-To-Use Oral Solution, Concentrated Oral Solution

3) By Oral Liquid: Viscous Oral Liquid, Non-Viscous Oral Liquid

4) By Dissolving Tablets: Fast-Dissolving Tablets, Slow-Dissolving Tablets

5) By Gel: High-Viscosity Gel, Low-Viscosity Gel

6) By Powder: Ready-To-Use Powder, Powder Requiring Mixing

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/artificial-saliva-global-market-report

Which Countries Are Leading the Artificial Saliva Market?

North America was the largest region in the artificial saliva market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial saliva market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16592

This Report Delivers Insight On:

1. How big is the artificial saliva market, and how is it changing globally?

2. Who are the major companies in the artificial saliva market, and how are they performing?

3. What are the key opportunities and risks in the artificial saliva market right now?

4. Which products or customer segments are growing the most in the artificial saliva market?

5. What factors are helping or slowing down the growth of the artificial saliva market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model